NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 17 filers reported holding NOVUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $22,000 | – | 10,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,785,000 | $818,000 | 0.05% |
| Orbimed Advisors | 3,183,314 | $1,459,000 | 0.02% |
| Virtu Financial LLC | 92,113 | $42,000 | 0.01% |
| Bayesian Capital Management, LP | 11,601 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Rockefeller Capital Management L.P. | 30,000 | $14,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 12,775 | $5,000 | 0.00% |
| BlackRock Inc. | 6,434 | $3,000 | 0.00% |
| Citadel Advisors | 54,279 | $25,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 18,380 | $8,000 | 0.00% |